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ABSTRACT 
 
Cryptosporidiosis is an infection caused by Cryptosporidium; a protozoan parasite that infects 
the gastrointestinal tract. The infection is of major public health concern in both developed 
and developing countries. Faecal samples were collected from 160 in-patient adults, with 
complaint of diarrhoea, admitted at Victoria hospital in Alice, Nkonkobe Municipality. 
Twenty apparently healthy subjects were included as controls. All diarrhoea positive patients 
were interviewed to record socio-demographic information, water supply and animal contact. 
Initial screening was carried out by microscopy and ELISA to detect positive 
Cryptosporidium. Genomic DNA was extracted from microscopically positive samples and a 
PCR reaction was perform to amplify the (18S) SSUrRNA gene for further identification and 
epidemiology of Cryptosporidium. Data were analysed using Pearson‘s χ2 and Fisher‘s exact 
test to assess the univariate association between Cryptosporidium infection and the possible 
risk factors. Of the 180 subjects screened for cryptosporidial infection, Cryptosporidium 
antigen was detected in 122 giving an overall prevalence of 67.8%. In HIV-positive diarrhoea 
patients, prevalence increased with ages; between 31-43 (mean age 36.5 yr) and 70-82 (mean 
age 75.8 yr) had a higher prevalence (100%) of the antigen than 18-30 (mean age 23.2 yr) 
and 83-95 (mean age 88.8 yr) (50.0%) in HIV-positive diarrhoea patients (P > 0.05). In HIV-
negative diarrhoea patients, prevalence was highest in the 18-30 (mean age 23.2 yr) (87.5%) 
and least (35.7%) in those aged 83-95 (mean age 88.8 yr) (P > 0.05). Cryptosporidium 
antigen was higher in females than in males. Of 115 females (mean age 46.7yr) who 
participated in the study, antigen was detected in 90 (78.2%) against 32 (71.1%) of 45 males 
(mean age 42.6yr). None of the 20 apparently healthy control subjects was found to be 
infected with Cryptosporidium. Cryptosporidium was detected in 27 HIV-positive and 97 
HIV-negative diarrhoea patients by any one of the techniques. Antigen detection by ELISA 
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showed the highest positivity 96 (76.8%) in HIV- negative and 26 (74.3%) in HIV- positive 
diarrhoea patients. PCR detected eighty-nine (71.2%) cases in HIV-negative and 23 (65.7%) 
in HIV-positive patients with diarrhoea. Only 13 (37.1%) HIV-positive and 34 (27.2%) HIV-
negative diarrhoea patients were found positive for Cryptosporidium by modified ZN. No 
significant difference was observed in sensitivity of antigen detection by ELISA and PCR 
(96.9%) in HIV-negative diarrhoea patients, respectively. Specificity of the staining 
technique was 88.9% in HIV-positive and 96.6% in HIV-negative diarrhoea patients. No 
significant difference was found in specificity of antigen detection by ELISA and PCR in 
HIV-positive and HIV-negative diarrhoea patients, respectively. Positive predictive value of 
ZN staining in both HIV-positive and HIV-negative diarrhoea patients (92.3 and 96.9%) was 
statistically higher than ELISA and PCR. No significant difference was observed in negative 
predictive value of ZN technique for detection of Cryptosporidium between HIV-positive and 
HIV- negative diarrhoea patients. Differences found in prevalence rates due to water source, 
suggest that the high infection rates of specific groups are associated with their exposure to 
the contaminated water supply. The results indicate that Cryptosporidium infection is highly 
prevalent in adult faecal specimens in the Nkonkobe Municipality, an indication of active 
infection that is likely to emerge as major human pathogen in this location due to 
socioeconomic changes which favour transmission. However, sequencing analysis is required 
to differentiate between Cryptosporidium genotypes in the various outbreaks.  
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CHAPTER ONE 
1.0   Introduction 
The credit for the discovery of Cryptosporidium species dates back to Ernest Edward Tyzzer, 
who in 1907, described a cell-associated organism in the gastric mucosa of mice, as well as 
named two important species: Cryptosporidium muris and Cryptosporidium parvum (Keusch 
et al., 1995). He provided the name ―Cryptosporidium‘ because of the uncertain taxonomic 
status of the oocysts. For several decades, Cryptosporidium was thought to be a rare 
opportunistic animal pathogen, but later on it was identified at the Johns Hopkins School of 
Medicine as the causative agent of human cryptosporidiosis that is now globally distributed 
worldwide (Flanigan and Soave, 1993).  
Cryptosporidiosis, caused by Cryptosporidium species remains one of the most important 
health problems globally and a leading cause of morbidity and mortality in 
immunocompromised adults, especially in developing countries requiring often 
hospitalization (WHO, 2006). They are unicellular parasite approximately 3-4 microns in 
diameter (approximately half the size of a red blood cell).  Therefore, it can‘t be seen with the 
naked eye. 
In humans, the pathogenesis infection mechanism of Cryptosporidium species was first 
recognised in 1976, where the ingested oocyst released sporozoites, which subsequently 
attached to and invaded the intestinal epithelial cells (Adjei et al., 2003). Reported analysis 
has showed that the organism infiltrates epithelial cells in the small intestine, where it 
completes its life cycle and causes both water and food-borne outbreaks of cryptosporidiosis 
(Adjei et al., 2003). To date, all the cryptosporidiosis outbreaks occurring worldwide have 
been caused by  Cryptosporidium hominis and  Cryptosporidium parvum, with several being 
associated with consumption of drinking water or exposure to recreational water 
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contaminated with Cryptosporidium oocysts of zoonotic and anthroponotic origins 
(Insulander et al., 2005). Due to the size and frequency of these outbreaks, cryptosporidiosis 
became a serious public health issue worldwide and prompted re-evaluation of the 
microbiological standards for drinking water by health authorities in developed and 
developing countries, especially in South Africa. 
  In addition, this incurable parasitic organism has gained much attention in the last 20 years 
as a clinically important human pathogenic disease that gives rise to a chronic, life 
threatening condition in immunocompromised individuals, particularly those with Human 
Immunodeficiency Virus (HIV), acute gastro-enteritis and diarrhoea in healthy people 
(Pieniazak et al., 1999). In an immunocompetent host, the organism usually produces a short-
term and self-limited diarrhoea illness, while in immunodeficient individuals or those 
undergoing cancer chemotherapy, infection is often prolonged resulting in significant 
morbidity due to diarrhoea and dehydration, as well as bile duct obstruction with jaundice or 
pancreatitis (Aboul-Magd et al., 2000). 
Various therapeutic drugs (anti-infective nitazoxanide (NTZ), Paromomycin, and Highly 
active antiretroviral therapy ( HAART) have been used as an attempt to treat 
Cryptosporidium species (C. spp) infection in humans, but are usually unsuccessful with 
partial limits. Currently, there is no broad effective therapy for Cryptosporidium parasite 
infection (Flanigan et al., 2001). 
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1.1 Problem statement  
Cryptosporidium parasites have been estimated to infect up to 500 million people annually in 
developing countries. In Africa, about 20 to 35% are infected with the organism and 32.5 to 
40% harbour this organism in sub-Saharan Africa (Kfir et al., 2000). A prevalence as high as 
32% were reported among children in Guatemala, with a significant variation between female 
(44%) and male (17%) children (Lee et al., 2005). In Malawi, molecular epidemiologic 
studies of cryptosporidiosis in children showed that 41 of 43 were infected with 
Cryptosporidium hominis and only 2 with Cryptosporidium parvum, while in Korea, a 
prevalence of 1% was reported among HIV patients (Lee et al., 2005). 
In Tanzania a prevalence of about 17.3% was documented amongst HIV patients (Abdel- 
Messih et al., 2005).  In Guinea Bissau, Cryptosporidium parvum had a prevalence of 7.7% 
and was the second most common parasite with a marked seasonal variation, with peak 
prevalence found consistently at the beginning or before the rainy seasons. In the Republic of 
South Africa, a prevalence rate of 5.6 to 8.5% of Giardia cysts and Cryptosporidium oocysts 
were found in all types of water tested including surface water, sewage or treated effluents 
respectively (Kfir et al., 2000).   
A reported study in Venda, South Africa showed that Cryptosporidium infection was the 
second most common enteric pathogen isolated from children with gastroenteritis, with 
infection rates varying between 1.2 and 20.9% according to season with the highest 
prevalence in the summer months (Obi and Bessong, 2002). Relatively few studies have been 
reported on genotype distribution data for Cryptosporidium in South Africa, particularly in 
the Eastern Cape region. Thus this research is to determine the prevalence and species 
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distribution of Cryptosporidium among diarrhoea and control patients in the South African 
Nkonkobe Municipality of the Eastern Cape Province.    
1.2 Research hypothesis  
Cryptosporidium species is prevalent among HIV-positive and HIV-negative diarrhoea 
patients in Nkonkobe Municipality of the Eastern Cape Province, and may elaborate distinct 
genotypes from those of other geographical regions. 
1.3 Overall objectives 
To delineate Cryptosporidium prevalence in HIV-positive and HIV-negative diarrhoea 
patients in the Nkonkobe Municipality of the Eastern Cape Province. 
1.4  Specific objectives: 
1 To detect Cryptosporidium antigens in facal samples obtained from patients with 
diarrhoea. 
2 To determine the prevalence of cryptosporidiosis in HIV-positive and HIV-negative 
patients attending the Victoria Hospital in Alice between April 2009 and January 
2010.  
3 To establish if there is a relationship between antigenemia and oocysts presence in the 
stool sample obtained. 
4 To determine the genotypes profile in the study area for the period of May 2010 to 
July 2010. 
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CHAPTER TWO 
2.0 LITERATURE REVIEW 
2.1 Cryptosporidium species 
Cryptosporidium species are an enteric protozoan pathogen that causes a diarrhoea illness 
called cryptosporidiosis (Fayer et al., 2000). The parasite invades and resides in epithelial 
cells, most commonly in the small intestines of multiple mammalian species. However, the 
association of the organism with disease was first described after 48 years in both turkeys and 
cattle (Panciera et al., 1971). 
There are fourteen named species of Cryptosporidium of which Cryptosporidium hominis 
(previously known as Cryptosporidium parvum human genotype or genotype I), is the species 
that almost exclusively infects humans. Cryptosporidium parvum (previously known as the 
Cryptosporidium parvum bovine genotype or genotype II) can infect not only humans but 
also ruminants and perhaps a few other animals (Sestak et al., 2002). Other species that infect 
human but are less common include Cryptosporidium  andersoni (cattle), Cryptosporidium 
baileyi (chicken and some other birds), Cryptosporidium canis (dogs), Cryptosporidium felis 
(cats), Cryptosporidium galli (birds), Cryptosporidium meleagridis (birds and humans), 
Cryptosporidium molnari (fish), Cryptosporidium muris (rodents and some other mammals), 
Cryptosporidium wrairi (guinea pigs), Cryptosporidium saurophilum (lizards and snakes), 
and Cryptosporidium serpentis (snakes and lizards) (Xiao et al., 2004). Recent literature has 
also described Cryptosporidium parvum as the most common species isolated from human 
stools from diarrhoea infected and non-infected individuals (Abdel-Messih et al., 2005). 
There is genetic heterogeneity among Cryptosporidium species isolated from humans, thus 
research surveys suggest that  Cryptosporidium species undergoes genetic changes following 
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human infection and/or that there may be distinct pathways of C. species transmission from 
bovine to human (Carryway et al., 2001). 
2.2 Classification 
Cryptosporidium species are classified as eukaryotes in the Phylum Apicomplexa (possessing 
an apical complex of secretory organelles), Class Sporozoasida (reproduce by asexual and 
sexual cycles, with oocysts formation), Subclass Coccidiasina (life cycle involving 
merogony, gametogony and sporogony), Order Eucoccidiida (schizogony occurs), Suborder 
Eimeriina (independent micro and macrogamy development), Family cryptosporiidae (4 
naked sporozoites within oocysts) (Tzipori and Widmer, 2000). 
Due to the relative uniform appearance, different genotypes have shown that some are very 
host specific while others have a broad host range and these have been utilized to classify 
Cryptosporidium spp into 14 valid species that are currently recognised on the basis of oocyst 
morphology and site of infection (Cryptosporidium parvum, Cryptosporidium hominis, 
Cryptosporidium muris, Cryptosporidium meleagridis, Cryptosporidium baileyi,  
Cryptosporidium serpentis, Cryptosporidium nasorum, Cryptosporidium felis,  
Cryptosporidium andersoni, Cryptosporidium canis, Cryptosporidium galli, Cryptosporidium 
molnari,  Cryptosporidium wrairi, Cryptosporidium saurophilum) (Hoepelman and 
O‘Donoghue, 2004). Among these species, only Cryptosporidium parvum and 
Cryptosporidium hominis are responsible for most human cases of infection with some 
geographical differences (Xiao and Fayer, 2008). While others are known to have less 
infection in humans.  
PCR analysis of the 18S rRNA based on Cryptosporidium felis and Cryptosporidium dog 
type has been implicated as an unusual potential causative agent in immunocompetent 
individuals after morphometric evaluation of oocysts isolated from human faeces in England 
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(Pedraza-Diaz et al., 2000). Additionally, new Cryptosporidium spp genotypes such as 
Cryptosporidium cervine have been identified in human stools (Ong et al., 2002). It appears 
likely that other species may cause occasional zoonotic infections in humans in the future 
through which the sporozoites exit during excystation. 
2.2.1 Taxonomy 
The genus Cryptosporidium spp is classified taxonomically within the same group as other 
coccidian parasites such as Toxoplasma, Eimeria and Isospora spp. A key difference between 
Cryptosporidium spp and other coccidian parasites is that the organism progresses through a 
complex life cycle characterised by the host‘s expulsion of double-walled, sporulated, and 
immediately infective sporozoites oocysts excyt. 
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Table 2.0:  Recognized Cryptosporidium species, their predominant host specificities and    
primary site of infection (Egyed et al., 2003) 
Species 
C. hominis 
C. parvum 
C. baileyi 
C. meleagridis 
C. felis 
C.canis 
C. suis 
C. muris 
C. andersoni 
C. wrairi 
C. galli 
C. serpentis 
C. saurophilum 
C. molnari 
Predominant host 
Humans 
 Mammals 
Chickens 
Turkey, humans 
Cats 
Dogs 
Pigs 
Rodents, ruminants 
Cattle, camel 
Guinea pigs 
Birds 
Snakes 
Lizards 
Sea bass, sea bream 
Primary site of infection 
Small intestine 
Small intestine 
Brusa of fabricius, cloaca 
Small intestine 
Small intestine 
Small intestine 
Small intestine 
Stomach 
Abomasum 
Small intestine 
Stomach 
Stomach, small intestine 
Stomach, small intestine 
Stomach, small intestine 
waterborne 
    Yes 
     No 
     No 
     No 
     No 
     No 
     No 
     No 
     No 
No 
     No 
     No 
     No 
     No  
Reference 
Morgan-Ryan et al., 2002 
Tyzzer, 1907 
Ditrich et al., 1991 
McDougald, 1998 
Pedraza- Diaz et al., 2001 
Pedraza-Diaz et al., 2001 
Xiao et al., 2002 
Palmer et al., 1990 
Pieniazak et al., 1999 
Widmer et al., 2000 
Ryan et al., 2003 
Ryan et al., 2003 
Ryan et al., 2003 
Ryan et al., 2003 
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Table 2.1: Morphometric characterization of oocysts (Sargent et al., 1998) 
Species  Measure (µm) Reference 
C. hominis 
C. parvum 
C. baileyi 
C. meleagridis 
C. felis 
C. canis 
 
 
C. suis 
C. muris 
4.9 x 5.2 (4.4-5.4 x 4.4-5.9) 
5.0 x 4.5 (4.5-5.4 x 4.2-5.0) 
6.1 ± 0.4 x 4.8 ± 0.2                      
4.0 x 4.5 
4.0 x 4.6 (3.0-4.0 x 3.2-5.1) 
4.7 x 5.0 (3.7-5.9 x 3.7-5.9) 
4.2 x 4.8 (3.8-4.6 x 4.6-5.1) 
4.2 x 4.6 ( 4.0-4.3 x 4.4-4.9) 
5.6 x 7.4 ( 5.3-6.5 x 6.6-7.9) 
6.1 x 8.1 ( 5.6-6.4 x 8.0-9.0) 
Morgan-Ryan et al., 2002 
Upton and Current, 1985 
Ditrich et al., 1991 
Fayer et al., 1998 
Sargent et al, 1998 
Fayer et al., 2001 
Fall et al., 2004 
Ryan, 2004 
Upton and Current, 1985 
Palmer et al., 1990. 
 
 
2.3 Morphology of the oocyst 
The small sizes of Cryptosporidium oocysts for the various species are difficult to distinguish 
from each other during routine fecal examination based solely on morphology by light 
microscopy (Fall et al., 2003).  Oocysts are spherical in appearance, and have many distinct 
phases.  They contain four parallel sporozoites surrounded by a tough protective smooth 
oocyst wall, measuring 3-6µm in diameter (Fayer et al., 2000) (Fig 2.0). 
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Figure 2.0: Cryptosporidium oocyts (Upton and Curent, 2002). 
In the wall, a faint suture can be seen through which the sporozoites exit during excystation 
(Morgan- Ryan et al., 2002). Depending on the host species, recovered oocysts can vary in 
size (3 to 8 pm in width by 3 to 9 pm in length) and they consist of many small granules and a 
membrane-bound globule with a residuum that is extremely resilient to various inhospitable 
environmental conditions (Fayer et al., 2004).  
2.3.1 Life cycle 
Cryptosporidium species are reported to have a monoxenous life cycle where all stages of 
development (asexual and sexual) occur within one host to form oocysts (O'Donoghue, 
2002). Each oocyst contains four infective stages termed sporozoites which are fully 
sporulated when excreted by the host into the environment. The naked nucleus sporozoites 
chromosomes consisting of 10.1-10.4 million base pairs of DNA with very few introns are 
released along with parasitized epithelial cells of the Cryptosporidium by the infected host 
through faeces and possibly other routes such as respiratory secretions (Bankier et al., 2003). 
Ingested oocysts excyst in the ileum, releasing sporozoites that are capable of penetrating 
individual epithelial cells in this region (O'Donoghue, 2002). 
Cryptosporidium is capable of completing all stages of its development (asexual and sexual) 
within a single host as shown in Fig. 2.1 below (Chen et al., 2002). Unlike other coccidian 
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species, the organism does not require a period of maturation (sporulation) outside the host to 
become infectious. The thick- walled oocysts are fully sporulated and infectious when 
excreted in the feces of an infected host (O‘ Donoghue, 2002). 
The life cycle of Cryptosporidium species progresses through five phases, where it begins 
with the ingestion of oocysts by the new host. When these oocyts are ingested, the suture in 
the oocyst wall opens (excystation), triggered by the body temperature and the interaction 
with stomach acid, bile salt and pancreatic enzymes. Four infective motile sporozoites are 
released from the cyst to produce thin-walled and thick-walled oocysts that invade the small 
intestine of the host and infect the intestinal epithelia cells (enterocytes), mainly in the 
jejunum and ileum. The freed sporozoites attach to epithelial cells and become enveloped 
within parasitophorous vacuoles, developing attachment organelles, a stage referred as 
trophozoites. Trophozoites reside beneath the cell membrane of the epithelial cells but 
outside the cytoplasm, where they transform into several life stages in an asexual merogony, 
releasing 8 and 4 merozoites respectively.  
The four merozoites released from the second merogony give rise to sexual developmental 
stages, through gametogony to produce microgamonts (male) and macrogamonts (female). 
The release of microgametes, and their fusion with macrogametes give rise to a zygote which 
undergoes further two asexual divisions to form the environmentally robust resistant oocysts 
containing 4 sporozoites (Smith et al., 2004). The majority of oocysts that are produced at 
this stage are usually thick-walled and are excreted with fecal materials from the host. Thin-
walled oocysts can excyst within the same host and start a new life cycle, known as 
autoinfection (O‘Donoghue et al., 2002). This may lead to a heavily infected epithelium of 
the small intestine, resulting in malabsorptive or secretory diarrhoea characterized by copious 
volume of fluid feces that may contain blood, mucus, and /or bile (O‘Donoghue et al., 2002). 
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The infectious stage of this disease may persist for several days or months depending on the 
parasite host.  
 
 
 
Figure 2.1: Life cycle of Cryptosporidium (Chen et al., 2002). 
 
 
2.4 Transmission of infection 
Evidence from several investigations suggests that transmission of Cryptosporidium is 
epidemiologically linked via the oocyst, where it is transmitted from an infected host to a 
susceptible host by the fecal-oral route. The infectious stage of the parasite is the oocyst 
which is excreted in great numbers along with faeces of infected hosts. The infective dose is 
not accurately known, but is believed to be very low (Egger et al., 2000). However, a median 
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reported an infectious dose of 132 oocysts in healthy adult volunteers. A mathematical model 
based on data from the Milwaukee outbreak suggested that some individuals developed 
cryptosporidiosis following the ingestion of only one oocyst (Mac Kenzie et al., 1994; 
DuPont et al., 1995). 
 
During the exogenous stage of the organism, the oocyst is difficult to remove from drinking 
water supplies because of its resistance to chlorine disinfection and inefficiency in filtering 
(Xiao et al., 2004). A variety of commercial disinfectants and chemotherapeutic treatment 
have been used in an attempt to kill sporozoites within oocysts. However, most of these have 
little or no effect on parasite infectivity because they are resistant to a wild range of 
environmental conditions even when Cryptosporidium parvum oocysts are exposed to Ultra-
violet (UV) light for 4 hours (Bankier et al., 2003).  
 
Laboratory studies have shown that oocysts stored in aqueous solutions have remained viable 
for up to 1 year at ambient temperature of 15 – 20oC and for up to two years when frozen at – 
80
o
C. Infectivity was lost after oocysts were heated to 65
o
C for at least 30 minutes. Snap 
freezing has been shown to affect oocysts while slow freezing is less effective. Some oocysts 
can survive freezing at -22
o
C for up to one year (O'Donoghue, 2002).  
In humans, the pathogenesis infection mechanism was first recognised in 1976, where the 
ingested oocyst released sporozoites, which subsequently attach to and invade the intestinal 
epithelial cells (Adjei et al., 2003). Reported analysis shown that the organism infiltrates 
epithelial cells in the small intestine, where it completes its life cycle and causes both water-
borne and food-borne outbreaks of cryptosporidiosis (Adjei et al., 2003). To date, all the 
cryptosporidiosis outbreaks occurring worldwide have been caused by Cryptosporidium 
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hominis and Cryptosporidium parvum, with several being associated with consumption of 
drinking water or exposure to recreational water contaminated with Cryptosporidium oocysts 
of zoonotic and anthroponotic origins (Insulander et al., 2005). Due to the size and frequency 
of these outbreaks, cryptosporidiosis became a serious public health issue worldwide and 
prompted re-evaluation of the microbiological standards for drinking water by health 
authorities in developed and developing countries, especially in South Africa. 
 
In various individuals with acquired immunodeficiency syndrome (AIDS), the frequency of 
diarrhoea increases with an increase in impaired immune function. However, 
cryptosporidiosis may also resolve spontaneously in Human Immunodeficiency Virus (HIV) 
patients anywhere along the spectrum, thus complicating the interpretation of uncontrolled 
treatment data (Blagburn et al., 2004). For the most part, the disease can be complicated in 
patients, where it manifests as chronic diarrhoea lasting 4 months or a year. In several cases 
the infected individuals may produce up to 15 litre/day of fecal matter (Riggs, 2002).  
Volunteer transmission studies have shown that cryptosporidiosis in immunocompetent 
adults normally present itself as an acute self-limiting watery diarrhoea that can persist from a 
period of several days up to one month with substantial morbidity and mortality among 
acquired immunodeficiency syndrome (AIDs) patients and infants, thus contributing a 
decreased lifepan (Blagburn et al., 2004). In addition to AIDS, immunological deficiencies 
and other conditions associated with protracted cryptosporidiosis include congenital 
hypogammaglobulinemia, concurrent viral infections, malnutrition, and exogenous 
immunosuppression (Blagburn et al., 2004). In childhood, respiratory cryptosporidiosis 
associated with or without bloody mucous has been increasingly reported, particularly 
children from 2 to 4years. Pulmonary symptoms are about three-fold more frequent in 
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children admitted to hospital with cryptosporidal infection than in children with other 
intestinal pathogens. However, infection by Crptosporidium parvum has been reported in six 
continents and identified in patients aged 3 days to 95 years old (Blagburn et al., 2004).  
Other frequent symptoms and voluminous bowel movements can contribute to rapid weight 
loss and dehydration, including abdominal cramping (Arrowood and Sterling, 2000). 
2.4.1 Routes of transmission  
Collectively, the various species of Cryptosporidium have a broad host range affecting 
gastro-intestinal epithelial cells. The durability of oocysts, along with their diminutive size, 
lend themselves to the incurable transmittable diseases via municipal drinking water, as they 
can survive many disinfectants, thus having the potential to cause community- wide 
outbreaks (Robertson and Gjerde, 2007). Outbreaks illustrate different routes of the 
transmitted diseases namely person-to-person contact with infected patients (family members, 
health care workers, users of communal swimming pools and travellers), human-animal 
contact (zoonosis) (veterinarians, farmers), or via indirect transmission through the 
environment (particularly by water) (Chen et al., 2002). The guidelines of world health 
organisation (WHO) for drinking water, classifies Cryptosporidium as a pathogen of 
significant public health importance (WHO, 2006).  
 
2.4.2 Epidemiological distribution of infection in humans 
The prevalence of this infection varies widely from country to country and from one region to 
another. However, diarrhoea infection is much greater in developing countries than in 
developed countries, whereby infection is influenced by ethnic background, gender, 
socioeconomic conditions, different locations and age group (Xiao et al., 2004). Research 
surveys have been conducted to gain some idea about the prevalence of the parasite in 
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industrialised nations. An average of about 2-3 and 5% of patients hospitalized for diarrhoea 
in United Kingdom and United States are infected with chronic cryptosporidiosis and 40% in 
some third world countries (Xiao et al., 2004). The reported analysis of 29 storm water 
samples in the United States revealed the presence of 14 Cryptosporidium genotype oocysts 
each year for every square meter of surface area (Xiao et al., 2004). 
 
A longitudinal study of Cryptosporidium infections in children in North Eastern Brazil 
documented a cryptosporidiosis prevalence of 94% (Lee et al., 2005). The most common 
symptoms were persistent diarrhoea (16.5%) and acute diarrhoea (8.4%) (Xiao et al., 2004). 
Analysis of stool specimens from the immunocompetent, adult population with 
gastrointestinal symptoms revealed a prevalence of infection close to 2% in Germany (Steeb 
et al., 1987). Remarkably, children aged 1-14 years, were found with prevalence close to 2% 
(Krause et al., 1995). As expected, the prevalence of cryptosporidiosis was higher (4-7.7%) 
among Human Immunodeficiency Virus (HIV) patients (Heise et al., 1988). 
Cryptosporidiosis in the Netherlands was found to be responsible for 2.2 % of gastroenteritis 
cases. The prevalence was found to be highest in patients with acute diarrhoea complaints 
(lasting < 7 days) being 5.4%. In patients with persistent diarrhoea complaints, the prevalence 
of Cryptosporidium spp. was found to be 3.3% (Mank, 1997).  
 
Furthermore, the distribution of infection appears to be age-related, with the highest 
prevalence of 7.0% found in patients between 0 and 4 years of age whereas the lowest 
prevalence (1.1%) was found in patients between 45 and 65 years of age. However, 
cryptosporidiosis in the Netherlands has a seasonal peak and is most frequently found in 
patients with diarrhoea complaints in the late summer (Mank, 1997; Mank et al., 1998).  In 
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the region of Aragon, Cryptosporidium oocysts were identified in 87 (1.93%) patients. 
(Clavel et al., 1996).  
 
A prospective study in Acquired Immune Deficiency Syndrome (AIDS) patients with chronic 
diarrhoea in the Madrid area, displayed the overall prevalence of intestinal cryptosporidiosis 
was 15.6%. The prevalence was found be higher in homosexual patients (33.3%) than in 
intravenous drug abusers (10.6%). Extra-intestinal infection was present in 30% of the 
patients with known intestinal cryptosporidiosis (Lopez-Velez et al., 1995). Eight of the 13 
(61.5%) patients with extra- intestinal cryptosporidiosis had Cryptosporidium in the bile and 
7 of 13 (16.28%) had it in the sputum. Interestingly, of the seven patients with 
Cryptosporidium in the sputum, four had respiratory symptoms and an abnormal chest 
radiograph (Lopez-Velez et al., 1995). Cryptosporidium was the only organism detected in 
induced sputum and bronchoalveolar lavage specimens.  Another study performed in the 
Zaragoza area, found a prevalence of 3% to 8% in immunocompromised HIV-positive adults 
(Moles et al., 1998). 
 
2.4.2.1 Human-human transmission  
The mechanisms of human transmitted infections are usually caused by direct person to 
person fecal-oral transfer, as illustrated by health care centers. Transmissions have been 
reported in day care centers, veterinarians, within households, in urban communities and in 
public institutions where there is poor hygiene or inadequate sanitary conditions leading to a 
high prevalence of cryptosporidiosis in developing countries (Robertson et al., 2000). 
Another risk factor that is generally found in these studies include sexual practices that imply 
32 
 
oro-anal contact with diarrhoea or HIV/AID patients, which has lead to high yield exposure 
to Cryptosporidium world-wide (Alireza et al., 2009). 
 
2.4.2.2 Zoonosis (animal – human) 
Over the past 20 years cattle have been identified as a main reservoir host that carries the 
parasite which then was transmitted to humans (Sulaiman et al., 1998). The role of zoonotic 
infections in human cryptosporidiosis in developing countries appears much more important 
than in the industrialized world since 60 – 90% of human infections in developing countries 
results from Cryptosporidium parvum (WHO, 2006). Mixed Cryptosporidium zoonotic 
transmission among Cryptosporidium parvum and Cryptosporidium hominis have improved 
our knowledge of understanding about the prevalence of zoonotic infections in humans as the 
leading cause of persistent diarrhoea in developing countries, and this has led to a major 
threat to the South Africa water supply. However, a review study on Cryptosporidium spp 
suggests that only the cattle genotype of Cryptosporidium is capable of zoonotic transmission 
whereas the roles of companion animals are considered less important (Xiao et al., 2004).  
There are also molecular epidemiological studies documenting transmission of 
Cryptosporidium between humans and livestock by direct contact in animal handling 
(Casemore et al., 1997). The high prevalence of infection in cattle and sheep and the high 
numbers of oocysts shed by infected animals make cattle and sheep important sources of 
environmental contamination with Cryptosporidium oocysts that are able to infect humans. 
Waterfowl and insects are also known as transport vehicles of infection, where they  pick up 
oocysts from contact with human or cattle feces and may deposit them in water or on food 
(Graczyk et al., 2000; Szostakowska et al., 2004). However, the significance of waterfowl in 
contamination of watersheds with oocysts that may infect humans is unknown.   
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2.4.2.3 Transmission through water  
Previous studies indicate that Cryptosporidium is the most frequently recognized cause of 
recreational water associated outbreaks of gastroenteritis, particularly in treated (disinfected) 
venues. The risk of waterborne transmission of Cryptosporidium is a serious global issue in 
drinking water safety. Oocysts from this organism are extremely robust, prevalent in source 
water supplies and capable of surviving in the environment for extended periods of time. The 
importance of waterborne Cryptosporidium transmission is evaluated based on the number of 
waterborne cases reported and on the various economic, regulatory, recreational, 
environmental and social aspects of waterborne disease control (Haas and Rose, 1994).   
Outbreaks where many people are affected usually occur when surface water becomes 
contaminated through the discharge of untreated and treated sewage and run-off of manure 
(Juranek, 1995). Surveys have indicated that Cryptosporidium is found in all types of water 
sources, and their presence is more common in surface water than in groundwater 
(Glaberman et al., 2002). However, the highly environmentally resistant cyst of 
Cryptosporidium spp allows the pathogen to survive during water filtrations and chemical 
treatment such as chlorination. These levels may increase rapidly through contamination from 
agricultural and human effluents. In fact, the incidence of human cryptosporidiosis tends to 
increase during the spring and summer seasons in South Africa (O'Donoghue, 2002). 
Currently, no curative therapy exists for the complete removal of Cryptosporidium from an 
infected host. Therefore, the presence of this parasite in drinking water represents a serious 
threat to public health.  
 The relative importance of both human and agricultural pollution on surface water reserves 
has yet to be determined, but both sources have great potential for waterborne contamination, 
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as high numbers of Cryptosporidium have been isolated from agricultural and human effluent 
in many geographical locations (Smith & Rose, 1998).  
 
2.4.2.4 Transmission through food  
The consumption of certain foods such as raw milk and meat, farm-made apple cider, 
fermented milk, salads, raw vegetables has resulted in cases of human cryptosporidiosis 
(Casemore et al., 1997). Food borne transmission, although not a major route of infection is 
possible if food becomes fecally contaminated. Moreover, infections have been associated 
with inappropriate food handling and/or using contaminated water to wash food (Quiroz et 
al., 2000). Interestingly, eating of properly washed raw vegetables have been found to be a 
protecting factor against Cryptosporidium in a case-control study in the United Kingdom 
(UK) (Hunter, 2003). This could serve as a route and build-up of protective immunity. 
2.5 Characteristics relating to water borne transmission  
Several characteristics of Cryptosporidium facilitate waterborne transmission. These are: 
 
2.5.1 Extreme resistance to chemical disinfection  
Disinfection with chlorine has always been an important barrier for waterborne pathogens. 
However, the high resistance of Cryptosporidium oocysts against chlorine disinfection 
renders this process ineffective for oocysts inactivation in drinking water treatment (Ransome 
et al., 1993). Chlorine dioxide is slightly more effective, but still requires a high measure of 
disinfectant dose. However, exposure of Cryptosporidium oocysts to multiple disinfectants 
has shown to be more effective than was to be expected from both disinfectants alone and 
synergism between environmental stress and filtration has also been observed (Liyanage et 
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al., 1997). The multiple stresses that oocysts encounter in the environment and during 
treatment might limit the infectivity of oocysts. A previous study suggests that Ultra-Violet 
(UV) systems have a limited effect on Cryptosporidium viability, probably due to the use of 
in vitro viability assays that over-estimate infectivity (Clancy et al., 1998). More successive 
studies have shown that oocysts are sensitive to low or medium wavelength pressure Ultra-
Violet (UV), but this is not proven yet (Craik et al., 2001). 
 
2.5.2 Persistence in the environment  
Oocysts can survive for months in surface water and estuarine waters (over 12 weeks at 
20
o
C), but less in seawater (Robertson et al., 1992). However, under natural conditions, the 
survival rate of Cryptosporidium oocysts in water is very high. In other successive studies, 
survival was monitored with in vitro assays such as excystation or dye exclusion and it was 
confirmed that the longevity of oocysts in fresh water inactivation rate is 0.095 at 25, 20, 15 
and 4
o
C respectively (King et al., 2005). A longer period of survival (120 days) of oocysts in 
soil has also been reported. Oocysts in soil do not survive well when artificially 
frozen/thawed in the soil or under field conditions in Norwegian soil (Kato et al., 2002). 
 
2.5.3 Oocyst wall 
The disulfide bond-rich oocyst wall provides a protective barrier for infective sporozoites 
(Mitschlere et al., 1994).  Unlike other coccidians, the oocyst wall of Cryptosporidium is 
bilayered, consisting of a distinct inner and outer layer. This structure perhaps represents a 
unique feature of Cryptosporidium spp oocysts. However, the outer layer of the oocyst wall is 
comprised of acidic glycoproteins and is at least partially removed by treatment with sodium 
hypochlorite, an in vitro excystation solution (Reduker et al., 1985). Previous studies 
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revealed that the rigidity and elasticity of the oocyst wall is a consequence of the central 
glycolipid/lipoprotein layer, and the thick inner filamentous layer, which is believed to be 
composed of glycoproteins (Bonnin et al., 1991). 
Interestingly, researchers have examined the oocyst wall structure of Cryptosporidium and its 
susceptibility to different treatments. A filamentous array on the inner surface was seen by 
transmission electron microscopy following thin sectioning and negative staining of isolated 
oocyst walls. It was seen that this filamentous array can be depleted by digestion with 
proteinase K and trypsin, but pepsin was less effective. Ultrasonication of untreated oocyst 
walls produced almost no lysis. Treatment with proteinase K was the most effective in 
releasing the internal fibrillar layer from the oocyst wall, as compared to treatments with 
trypsin and pepsin. Chloroform treatment and phenol extraction did not disrupt the oocyst 
wall (Harris and Petry, 1999). 
 
2.5.4 Small size 
Compared to other protozoan parasites, the oocysts of Cryptosporidium are very small and 
are more difficult to remove during soil passage, in bank filtration and in rapid or slow sand 
filtration in drinking water treatment, thus making the organism a particular challenge to 
effective water treatment methods.  Although, the state in which oocysts in water suspension 
are attached to particles is important for water treatment through boiling. Little information is 
available on oocyst attachment to sand particles in batch experiments (Dai and Boll, 2003). 
2.5.5 High infectivity 
The infectivity of oocysts has shown to be very high, although uncertainty exists concerning 
the dose required to induce Cryptosporidium infection. Studies suggest that very small 
37 
 
inoculums are capable of inducing infection (Chappell et al., 1999). A comparative study 
completed a Cryptosporidium parvum human feeding investigation among healthy volunteers 
which determined that the dose at which 20 percent of the subjects were infected was 30 
oocysts while the median infective dose of Cryptosporidium parvum in healthy adult 
volunteers was 132 oocysts (DuPont et al., 1995).  Based on a mathematical model on data 
from previous outbreak, some individuals might develop cryptosporidiosis after ingestion of 
only one oocyst (Haas and Rose, 1999). 
Similar studies employing different Cryptosporidium spp isolates recorded doses causing 
infection in fifty percent of the population from below 100 to 1000 oocysts (Okhuysen et al., 
1999). Interestingly, an infectious dose did not significantly affect the severity of symptoms, 
length of the incubation, or number of oocysts shed. The risk of infection following ingestion 
of one oocyst has been estimated at 0.028 (Okhuysen et al., 1999). Significant virulence 
differences exist between strains of Cryptosporidium, but this may not accurately describe the 
infectivity of other species. However, during acute infection, oocysts can be found in high 
numbers in the feces of the host, although this is facilitated by auto-infection of the host. 
 
 2.5.6 Period of maturation  
Unlike other coccidian parasites and helminths, Cryptosporidium oocysts do not require a 
period of maturation of the oocysts after shedding with feces. They are immediately able to 
infect a new host when excreted by another (Okhuysen et al., 1999). 
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2.5.7 Environmental factors 
Cryptosporidium oocysts can persist and survive in the environment for several days or 
months. In general, aged oocysts are more susceptible to disruption by environmental 
changes and disinfectants. Temperature has been shown to have an effect on the ability of 
oocysts to survive in water, including seawater, at temperatures ranging from 4°C to 22°C. 
Under ambient conditions, the duration of oocyst infectivity decreases as the temperature 
increased from 4°C to 23°C (Pokorny et al., 2002). Warmer temperatures can accelerate 
oocyst degradation, although oocysts are known to remain infective up to 12 weeks when 
stored in water at 25°. At extreme temperatures, oocyst viability and infectivity are adversely 
affected. As the oocyst wall is composed of numerous proteins, their denaturation at elevated 
temperatures may disrupt oocyst wall integrity and expose the sporozoites to conditions 
detrimental to their survival (Harris and Petry, 1999).  
2.6 Metabolism of cryptosporidium species 
Analyses of the Cryptosporidium genomes have identified
 
some unique metabolic pathways 
and evidence for the heavy reliance
 
of Cryptosporidium on the host for nutrients and 
glycolysis
 
for energy metabolism. This information might have significant importance in the 
development of therapeutic agents against Cryptosporidium (Abrahamsen et al., 2004; Xiao 
and Ryan, 2008). The molecular and functional studies of proteins and enzymes involved in 
unique Cryptosporidium metabolic pathways would greatly deepen our understanding of the 
basic metabolism in the parasites. Since Cryptosporidium cannot synthesize fatty acids de 
novo. Instead, it possesses a giant type I fatty acid synthase (CpFAS1) that makes a very-
long-chain fatty acids using intermediate- or long-chain fatty acids as precursors (Zhou et al., 
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2003). The latter type of precursors probably has to be transported from the host cells through 
the parasitophorous vacuole membrane (PVM).  
 
In recent study, researchers have been able to localized three
 
Cryptosporidium proteins to the 
PVM (Zhu, 2004). These proteins included
 
an unusual fatty acyl coenzyme A binding protein 
(ACBP), one of the
 
two oxysterol binding protein-related proteins (ORP1), and a
 
long-chain-
fatty-acid elongase (LCE). Although the PVM
 
is mainly a host cell-derived membrane 
structure, it also contains
 
proteins from the parasite. Because all three proteins are known
 
to 
be involved in fatty acid metabolism, it is very likely that
 
the PVM may play an important 
role in lipid metabolism and/or
 
remodeling. However, Cryptosporidium lacks enzymes for the 
oxidation of fatty acids, indicating that fatty acids are not an energy source for this parasite. 
 
2.6.1 Amino acid metabolism 
Amino acids are the basic building blocks of proteins, Cryptosporidium apparently cannot 
synthesis any of them de novo. Despite all amino acids synthetic genes are missing from 
Cryptosporidium genome. Instead, the parasite possesses at least 11 amino acids transporters 
that scavenge amino acids from host cells and the intestinal lumen. Unlike P. falciparum, 
which only possesses one amino acid transporter (Abrahamsen et al., 2004). However, 
Cryptosporidium retains the capacity of intercoverting a limited number of amino acids such 
that glutamate produced by Guanosine monophosphate (GMP) synthetase can be recycled 
back to glutamine by glutaine synthetase, serine and glycine may be intercoverted by serine 
hydroxymethyl transferase (SHMT) within the folate metabolism pathway. Asparagine can 
be made from aspartate by asparagine synthetase, which might be important in the recycline 
of NH3 released by Adenosine monophosphate (AMP) deaminase (Madern et al., 2004). 
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2.7   Pathogenesis of cryptosporidium species  
Cryptosporidium possesses numerous surface glycoproteins thought to play a role in 
pathogenesis. The mechanism involved in the invasion of Cryptosporidium sporozoites
 
into 
epithelial cells is not clear. Thus far, the few antigens
 
shown to be important for the 
attachment and invasion of Cryptosporidium
 
into the host cell are all mucin-like 
glycoproteins such as
 
gp60 and gp900 (Xiao et al., 2002). GP900 localizes to the apical end 
of sporozoites and in micronemes of merozoites, where it attaches intimately to the 
microvillous membrane and causes loss of microvilli and effacement, which results in 
malabsorption. The organism immediately activates a second-signal pathways, such as the 
nuclear factor-kappa B (NF-κB) and Proto-oncogene protein pp60 (C-src) systems. 
Activation of (NF-κB) induces the production of cytokines and chemokines, such as 
interleukin-8 (IL-8), to trigger an inflammatory reaction and stimulates anti-apoptotic 
survival signals in directly infected cells (presumably facilitating the organism's ability to 
survive and propagate). Activation of C-src is associated with host-cell cytoskeletal 
reorganization and perhaps dysfunction of tight junctions (Cevallos et al., 2002). Human 
immunodeficiency virus (HIV) type 1 infection can further amplify damage by the action of 
soluble factors, such as tat protein with varying degrees of villous atrophy by an unknown 
mechanism, resulting in epithelial damage. 
Histological findings of severe villous atrophy, crypt hyperplasia and presence of several 
developmental stages on the mucosa have been found associated with an altered glucose-
stimulated Na
+
, water absorption, and increase in Cl
−
 secretion (Argenzio et al., 1990). 
However, glucose stimulated sodium absorption was inhibited, thereby increasing chlorine 
secretion, and epithelial cell damage. Therefore it is still a thought that diarrhoea results from 
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a combination of secretory sodium/glucose malabsorption due to villous atrophy and 
epithelial damage. 
Immunological and molecular methods have identified several possible virulence factors 
which may affect the adhesion of Cryptosporidium to the host intestinal epithelial layer such 
as ATP transport to cause membrane disruption (Riggs et al., 1997). These events could 
ultimately lead to malfunctioning in the small intestine epithelium, induced by 
Cryptosporidium parvum-infected individuals.  
 
Figure 2.2: Schematic representation of Cryptosporidium pathogenesis. (Clark and Sears, 
1996). 
Villi often are blunt, shorter, and wider than normal and are sometimes fused to other villi, 
whereas crypts are elongated and hyperplastic. Changes in villous and crypt structures may 
be accompanied by an inflammatory infiltrate consisting of lymphoid cells, macrophages, and 
neutrophils in the underlying lamina propria (Xiao et al., 2001). 
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2.7.1 Human immune responses to cryptosporidium infection   
Knowledge about the human immune response towards Cryptosporidium infection is poorly 
understood (Guk, 2003). In human hosts, cell-mediated immune responses by B and T 
lymphocytes, which includes the production of IgG, IgM, IgA, and IgE antibodies, are 
necessary to control cryptosporidiosis (Guk, 2003).  Deficiency in any of these immune cells 
can result in difficulty or inability to conquer Cryptosporidium infection, making 
cryptosporidiosis a particularly dangerous pathogen for AIDS patients. Although the 
mechanism by which Cryptosporidium  infection induces adaptive immune responses in host 
cells is not understood completely,  information on most immunocompetent animals were 
found susceptible to Cryptosporidium only when very young and then they rapidly developed 
innate resistance. In contrast, age related susceptibility to Cryptosporidium in humans is not 
clear. Persons of any age may acquire infection (Xiao et al., 2001).   
2.7.1.1 Clinical features 
The symptoms of cryptosporidiosis differ greatly between immunocompetent and 
immunocompromised hosts. In the immunocompetent patient, the disease is acute and self-
limiting, producing diarrhoea illness that typically occurs for one to two weeks. Children are 
much more susceptible to Cryptosporidium infections than other age groups, probably due to 
their immunological immaturity (Smith and Corcoran, 2004). However, infection takes 
advantage of the impaired or destroyed immune system, causing a persistent infection that 
seriously dehydrates the patient as up to 20 litres of excreta per day and ultimately results in a 
higher mortality rate (Keusch et al, 1995). The most common clinical signs of 
Cryptosporidium infection are profuse and watery diarrhoea. Other general signs include 
crampy abdominal pain, fever, nausea, vomiting and low grade fever (Smith and Corcoran, 
2004).  A plethora of such signs is often associated with a marked weight loss. Patients can 
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have chronic diarrhoea that can last for more than two months, shedding oocysts in stool 
during the entire period, which contributes to severe dehydration, weight loss and 
malnutrition, extended hospitalizations, and mortality (Shin et al., 2001). Thus, the duration 
and severity of clinical signs reflect the immune status of the patients.  
Due to the immunological deficiency, HIV/AIDS patients are at a high risk of contracting 
cryptosporidiosis. In such patients, infection produces persistent diarrhoea that worsens with 
time and eventually contributes to death. Infections are not always confined to the small 
intestine and parasites have been found in the oesophagus, stomach, appendix, colon and 
rectum (Smith and Corcoran, 2004). 
2.7.1.2 Absence of curative therapy 
Currently, no drug regimens are known to be effective in preventing the recurrence of 
cryptosporidiosis infection, despite in vitro and in vivo testing of hundreds of compounds.
  
One possible explanation for this is that Cryptosporidium establishes
 
a compartment within 
the host cell, which is morphologically different
 
from the setting used by related parasites. 
This unique parasitophorous
 
vacuole may somehow shelter the parasite from antimicrobial 
drugs
 
(Griffiths et al., 1998). 
Regardless of the significance of Cryptosporidium infection in childhood health, there has 
been a lack of serious effort to invest in the development of affordable and effective 
therapeutics specifically targeting Cryptosporidium species. Existing therapeutics for other 
apicomplexan diseases are ineffective against Cryptosporidium infection, perhaps because of 
the unique intracellular, extracytoplasmic location of Cryptosporidium and the poorly 
understood host-parasite interface. In addition, difficulties in laboratory ideal cell culture 
methods, have limited drug screening. 
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Clinical course of cryptosporidiosis depends largely on the immune status of the host, 
treatment with options vary
 
accordingly (Griffiths et al., 1998). Healthy persons with normal 
immune systems usually get better on their own. The recommended treatment is to drink 
plenty of fluids and to get extra rest. In immunocompetent adults and children, no
 
specific 
therapy is indicated, since the disease is self-limiting. Individuals with persistent diarrhoea, 
an underlying
 
immunodeficiency (HIV, congenital immunodeficiency,
 
etc.) might need 
special treatment from a health-care provider to replace fluids lost during the illness. 
However, some encouraging results following the use of supportive therapy remains the 
preferred option for the management of symptoms arising from the disease. Several drugs 
have been tested in the laboratory. An acknowledged report suggests that Paromomycin is an 
antimicrobial drug that can alleviate cryptosporidiosis symptoms with a reduction of oocyst 
excretion (Steiner et al., 1997). Paromomycin is typically administered at a dose of 500 mg 
four times daily for 4–8 weeks, with a recommended maintenance dose of 500 mg twice daily 
following the initial treatment period (Hoepelman, 1996). However, clinical evaluations of 
these drugs have been disappointing, mainly because they failed to clear the parasite from 
patients with HIV/AIDS. To date, anti-infective nitazoxanide (NTZ) have shown the most 
promise against Cryptosporidium.  
Nitazoxanide, also known as Alinia, is an antiprotozoal drug believed to interfere with the 
pyruvate ferredoxin oxidoreductase-mediated electron transfer reaction that is essential for 
anaerobic energy metabolism in the parasite (Herbert and Hoffman, 2002). Presently, 
nitazoxanide is the only drug approved by the US Food and Drug Administration (FDA) for 
the treatment of diarrhoea caused by Cryptosporidium in children. The drug was found to be 
effective in AIDS-related cryptosporidiosis during a double-blind placebo-controlled trial of 
45 
 
66 HIV patients in Mexico (Rossignol et al., 1998). When administered at a dose of 500 or 
1000 mg twice daily for 14 days, nitazoxanide resulted to a cure rate of 63% and 67% of 
patients, respectively. 
Co-administration of both drugs did not further reduce Cryptosporidium infectivity 
(Rossignol et al., 1998). A previous study revealed that HAART reduced diarrhoea from both 
cryptosporidiosis and microsporidiosis in HIV patients (Rossignol et al., 1998). As HAART 
reduces the viral load, CD4 T lymphocyte counts are increased and there was a delay in the 
onset of HIV-related opportunistic infections, including cryptosporidiosis. However, the 
therapy is not easily affordable for affected individuals in the developing world. 
2.7.1.3 Prevention 
As cryptosporidiosis is initiated by ingestion of infective oocysts, therefore control measures 
are aimed at reducing or preventing oocyst transmission. In locations such as hospitals, 
laboratories and day-care centers, contact with potential sources of infection should be 
minimized. This entails personal hygiene, proper handling and disposal of bio-hazardous 
wastes, and boiling of water prior to consumption. Individuals with weakened immune 
system are advised to always use a home micro-straining water filter, capable of removing 
particles less than 1 micrometer in size. Avoid sexual practices that can result in hand or 
mouth exposure to stool, avoid direct exposure to cattle and other farm animals. If exposure 
cannot be avoided, wash hands well immediately after contact (Roberson and Bruno, 1997). 
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2.8 Laboratory diagnosis  
Laboratory techniques are usually applied for identification of Cryptosporidium. The need to 
identify the organism in diarrhoea patients is useful to avoid misuse of antibiotics, to reduce 
the spread of the disease in a community, as well as to follow the need for control and 
preventive measures. For many years, microscopy has been the only tool available for the 
detection of parasites through inspection of blood smears, tissue specimens, feces, lymph 
node aspirates, bone marrow, and even cerebrospinal fluid (Cruz et al., 2006).  
Diagnosis of cryptosporidiosis is made microscopically by examination of stool samples for 
the presence of oocysts. Mature Cryptosporidium oocysts recovered from stool can be easily 
identified using differential staining methods such as safranin-methylene blue stain, modified 
Kinyoun‘s acid-fast method, Ziehl-Neelsen and DMSO-carbol fuchsin stain which stain 
oocysts red and counterstain the background. However, sample preparation for direct 
observation is time-consuming, labour intensive, and proper diagnosis depends on qualified 
laboratory technicians (Cruz et al., 2006). Because detection of Cryptosporidium is difficult, 
patients may be asked to submit several stool samples for identification. In endemic regions, 
where resources are limited, this proves to be difficult and misdiagnosis can significantly 
impact patient care. In reality, all major intestinal helminth infections are still solely 
dependent on microscopy for diagnosis. As for other parasite infections, many are confirmed 
by the use of microscopy in conjunction to other methods of diagnosis including serology-
based assays and more recently molecular-based assays. 
  
Evaluation of Cryptosporidium infection by serology is much more sensitive than detection 
of oocysts in stool samples, especially in populations chronically exposed to Cryptosporidium 
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through contaminated food or drinking water, and has been widely used for epidemiological 
studies (Moro and Schantz, 2009). Serology-based assays include the enzyme-linked 
immunosorbent assay (ELISA), also called enzyme immunoassay (EIA), and all its derived 
tests such as the Falcon assay screening test ELISA (FAST-ELISA) and the dot-ELISA. 
Other assays include the hemagglutination test, indirect or direct immunofluorescent antibody 
(IFA) or Direct immunofluorescent antibody (DFA) tests, complement fixation (CF) test, and 
immunoblotting and rapid diagnostic tests. Although the ease of use and turn-around times 
for serologic assays are similar to microscopy. It becomes important for individuals 
exhibiting low-parasitemia and/or who are asymptomatic (Moro and Schantz, 2009).  
Finally, having these tests readily available allows for the monitoring of parasite clearance 
following therapy. However, cross-reaction leading to false-positives and misdiagnosis is a 
problem, especially in Africa regions where more than one parasite is endemic (Burbelo et 
al., 2008). To a lesser extent but nonetheless important is the inability of antibody-detection 
tests to differentiate between past and currently active infection. Furthermore, antibody-
detection tests cannot be used in parasitic infections that do not develop a significant antibody 
response. This has been observed in some individuals carrying Echinococcus cysts (Moro and 
Schantz, 2009). For all these reasons, there is still a need to improve on the current diagnosis 
approaches available. Since the advent of the polymerase chain reaction (PCR), 
parasitologists have turned to molecular-based approaches in the hopes to better the existing 
diagnosis tools (Diez et al., 2007). 
The many limitations of microscopy and serology-based assays have influenced 
parasitologists towards the use of gene amplification methods made possible with the advent 
of polymerase chain reaction. PCR offers many advantages over other techniques for the 
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clinical and environmental detection of Cryptosporidium species and is capable of 
differentiating the taxonomic membership between C. strains that infect humans. Cost-
effective and amenable to quantitation, PCR allows for the analysis of multiple samples in a 
short time frame. Besides the traditional PCR, including nested and multiplexed PCR, the 
implementation of the quantitative PCR (q-PCR) for the detection of several parasitic 
infections have also emerged as possible new approaches for the diagnosis of parasitic 
diseases (Gasser, 2006). 
Molecular-based approaches based on nucleic acids have been found to offer greater 
sensitivity and specificity over the existing diagnostic tests. They permit the detection of 
infections from very low parasitized samples including those from asymptomatic patient‘s 
samples (Zarlenga and Higgins, 2001). Moreover, multiplexed PCR allows for the detection 
of multiple sequences in the same reaction tube proving useful in the diagnosis of several 
parasitic infections simultaneously (Gasser, 2006). 
q-PCR system unlike conventional PCR, allow for the quantification of the original 
template‘s concentration through the use of various fluorescent chemistries, such as 
Sybergreen, Taqman probes, fluorescence resonance energy transfer (FRET), and Scorpion 
primers (Muldrew, 2009). This eliminates the need to visualize the amplicons by gel 
electrophoresis thereby greatly reducing the risk of contamination and the introduction of 
false-positives. Running the multiplex assay not only reduced the cost per test but also 
allowed for a rapid turnaround time, in a single reaction tube even in very low parasitized 
samples and it allows for the high-throughput analysis of different sequences in one single-
closed tube reaction. It is a clear advantage over microscopy which is labour intensive and 
time-consuming with slow turnaround times especially during high-throughput settings. 
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These examples demonstrate that efficient and early diagnosis can directly impact patients 
care and that PCR-based approaches have the potential to help in making the right choice for 
treatment.  
Although DNA-based methods have shown excellent sensitivity and specificity, the 
introduction of these methods in daily laboratory practice is still uncommon especially in 
rural endemic regions. In addition, as observed with many serology-based assays, PCR-based 
methods also suffer by the lack of standardization (Murray and Cappello, 2005). DNA 
extraction, choice of primer sets, and use of various amplification protocols are all factors 
that may cause this diversification in results. Adding an automated DNA extraction step 
would certainly improve PCR assays for use in the diagnosis of parasitic diseases.                                                                                                                                                                                                                                                                                                   
However, the presence of inhibitors, sample contamination and precipitation of oocyst 
nucleic acids represent challenges facing the current PCR techniques. A shortcoming of PCR 
is that it does not directly assess viability (Toze, 1999). 
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CHAPTER THREE 
3.0 Materials and methods 
3.1 Study design, site and population 
Nkonkobe Municipality is one of the most populated amongst the administrative province of 
the Eastern Cape. There are 21 wards within the Nkonkobe municipality area. Approximately 
74% of people living within the area are indigent. About 20% of the population resides on the 
farms and scattered locations. Only about 19% of the population of Nkonkobe resides in 
locations, mostly Alice town (Fig 3.0: Ward 5) which accounts for the smallest population 
within Nkonkobe area and has a diversity of individuals with different socioeconomic 
potential and women are in the majority (52.55%). The majority of inhabitants, however, fall 
in the low socio-economic strata, where they lack proper sanitation, poor water services, high 
levels of unemployment and poverty (Xuza, 2007).  
 
 
 
 
 
 
Figure 3.0: Population distribution source, census 2001 
A significant decrease in Alice population has been noticed, which may be attributed to 
HIV/AIDS associated with the cryptosporidiosis epidemic. The population trends thus 
suggest that a comprehensive study of the impact of cryptosporidiosis is extremely crucial at 
the moment (Xuza, 2007). Since the estimated population is known to be 16,000 and using a 
margin of error of 0.05 and a critical standard score (z) of 1.96, for a 95% confidence interval 
51 
 
by a simple random sampling, the minimum number of respondents needed for the study is 
162.2. Victoria Hospital where our samples were collected, serves as a major hospital for the 
many surrounding villages found in Alice.  These surrounding villages from which the study 
subjects were drawn reside in deprived communities that are relatively undeveloped with 
poor service delivery (Fig 3.1). This condition may enhance the chances of Cryptosporidium 
transmission.  
 Figure 3.1: Nkonkobe Municipality villages 
3.2 Ethical issue and data collection 
This study was approved by Institutional Ethics Review Board of University of Fort Hare 
(UFH) through the Govan Mbeki Research Development Centre (GMRDC). A standardized 
questionnaire describing demographic characteristics including age, gender, socioeconomic 
status, route of transmission of infection and the sampling date were given to participants to 
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fill in. Household characteristics, including toilet facilities, and potable water, were also 
noted. When required, patients were interviewed in the local dialect by one of our group 
members before the collection of specimens. The aim of the research was explained to each 
patient; though their consent to participate was poor. Confidentiality of the voluntary 
participants was maintained.   
3.3 Patients and control  
A total of hundred and eighty (180) samples were collected individually from each patient 
between April 2009 and January 2010 at Victoria Hospital (Alice). Our study population 
consisted of patients with ages ranging from 18-95 (mean age 41.4 yr). These groups differ 
with respect to mean age, gender, source of water, contact with any farm animals, availability 
of sanitary facility and socioeconomic status. A sterile wide mounted plastic container was 
provided to all participants. The consistency of the stool specimens was graded by categories 
(watery, soft and hard) while waiting to be processed. Stool specimen comprised of 35 HIV-
positive diarrhoea patients, 125 diarrhoea patients without HIV and 20 controls, i.e healthy 
individuals without any history suggestive of cryptosporidiosis.  
 
3.4 Stool specimens and processing 
Fecal samples from 180 subjects were collected fresh in sterilized, wide mouthed plastic 
containers and transported to the Microbial Pathogenecity and Molecular Epidemiology 
Research Laboratory in the Department of Biochemistry and Microbiology, University of 
Fort Hare on ice and processed directly on arrival or kept refrigerated at -20
o
C without 
preservatives until processed.     
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3.5 Microbiological and immunological characterisation  
 
3.5.1  Parasite diagnosis of cryptosporidium oocysts 
Microscopic diagnoses of Cryptosporidium were performed by the Modified Ziehl-Neelsen 
(MZN) stain (Casemore et al., 2004). Briefly,
 
a drop of each fecal suspension was placed on a 
glass slide and spread
 
to form a thin smear. The slides were fixed
 
with either acetone or 
absolute methanol for 30 seconds and then flooded with carbol fuchsin
 
for 1 minute. After 
washing, slides were decolorized in 3%
 
acid-alcohol for between 15 sec and 1 minute, 
depending on the film
 
thickness. Slides were washed, counterstained with 3% malachite 
green for 2 minutes, washed again and dried on a slide warmer at 60°C, for 5minutes and 
then examined under
 
40 × objectives and 100 x oil immersion objectives to view oocysts.  
Visual oocyst count: The number of oocysts was determined by scanning through each slide 
randomly. This was done by moving three different parts of the slide each at a time across the 
x10 objective and looking out for the pinkish stained oocyst. Oocysts encountered were 
confirmed using 200–400× magnification on a Zeiss Axioscop epi-fluorescent microscope to 
confirm their internal morphology. Oocysts were oval or round shape approximately 4-5 µm 
in diameter and pink-red coloration (Fig 3.1). These were counted and their numbers 
recorded. Presence or absence of diarrhoea was recorded. Stained fecal smears on microscope 
slides were stored at room temperature. In cases where more than four Cryptosporidium 
oocysts were visualized, the sediment of the second tubes were utilized for DNA extraction 
within 2 weeks of preparation, and subsequent PCR detection. 
 
 
 
54 
 
3.5.2 Enzyme-linked immunosorbent assay  
3.5.2.1 Antigen detection 
A sandwich-type enzyme immunoassay amplification technology (Amplified IDEIA™ HP 
StAR™, Oxoid, UK) was used to analyze the fecal samples for detecting Cryptosporidium 
antigens according to the manufacturer‘s instructions. Briefly, a supernatant of fecal 
suspension was added to the wells of a microtiter plate coated with fluorescent monoclonal 
antibodies specific for Cryptosporidium antigen. Two hundred microlitres (200 µl) of horse-
radish peroxidise (HRP)-labelled mouse immunopure 1gG monoclonal anti-CSA conjugate 
was added to each well of the plate, covered, and incubated for 60 minutes at 20
o
C with 
shaking. The plate was washed with buffer (5 times) to remove unbound antibody conjugate; 
a colourless single-component enzyme substrate (Tetramethylbenzidine-(TMB) was added, 
incubated for 10 minutes at 20
o
C and observed for a colour change. A stop solution was 
added and the optical density (OD) was read in an ELISA plate reader (Rayto 2100C, CH) at 
an absorbance of 450 nm.  Cryptosporidial antigen was used as a positive control. The value 
for a positive reaction was calculated to be double the optical density value of the negative 
control. OD values > 0.05 were considered positive. For comparative evaluation of diagnostic 
techniques, sensitivity, specificity, positive predictive and negative predictive values and 
diagnostic efficacy of the two techniques were determined by standard formulae (Galen and 
Gambino, 1975).  
3.6   DNA extraction with zymo-(research) fecal kit 
DNA extraction using Zymo-research protocol was performed as per the manufacturers‘ 
instruction. Briefly, about 200mg faecal samples were added to a ZR bashing bead lysis tube, 
and lysed with 750µl lysis buffer. Sample tubes were homogenized and centrifuged at 
12,000xg for 1minute and 400µl of the supernatant were transferred to each orange top cover 
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and centrifuged again at 7000rpm for 1minute. The top tube fixed to the collection tubes was 
discarded and 1,200µl of faecal DNA binding buffer was added to the filtrate in the collection 
tube. 800µl of each mixture was transferred to a new Zymo-spin 11C column in a collection 
tube and was centrifuged at 10,000xg for 1minute. The step was repeated by discarding the 
liquid from the collection tube, fixed back to the top tube and another 800µl of the mixture 
was added and centrifuged for 1minute at the same temperature. Each top tube was placed 
into a new collection tube and 200µl DNA pre-wash buffer and was added centrifuged for 1 
minute at the same temperature. Five hundred microliter (500µl) fecal DNA wash buffer was 
added to the ―11C‖ tubes, centrifuged for 1minute and transferred to a new clean 1.5ml tube. 
100µl DNA elution buffer was added directly to the column matrix, centrifuged for 30sec to 
elute the DNA. Eluted DNA was transferred to the ‗green top‘ column, fixed in a clean 1.5ml 
tube. These were centrifuged finally at 8000xg for 1 minute. Extracted DNA was run in 2% 
electrophoresis gel to view bands.   
 
3.7 DNA amplification by PCR  
The gene fragment of interest of a 599-bp region of the small sub-unit (18S) rRNA of 
Cryptosporidium parvum, was amplified with the following primers CPF-5‘ 
GTGCCAGCAGCCGCGGTAAT-3‘ together with universal lower eukaryotic reverse primer 
CPR-(5‘- AAGCCGCAGGCTCCACTCCT-3‘), which correspond, respectively, to positions 
542 to 561 on the coding strand and positions 1,140 to 1,121 on the negative strand of 
GenBank sequence Af093489. The reactions were performed with Perkin-Elmer 
thermocycler model 9600 in 0.5 ml thin-wall eppendorf tubes (Sturbaum et al., 2001; Bialek 
et al, 2002). Each 50µl PCR tube reaction contained PCR buffer (10 mM Tris-HCl, 50 mM 
KCl [pH 8.3]), 1.5 mM MgCl2, 200µM dNTPs, 0.5µM of each specific oligonucleotide 
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primers, and 2.5 U of Taq DNA polymerase (Boehringer), 5µl of purified DNA extract. After 
a fifteen-minute hot start at 95
o
C, the reactions went through 35 cycles of denaturation at 
94°C for 1minute, annealing at 65°C for 1minute, and extension at 72°C for 1minute, 
followed by a 72°C incubation for 15 minutes for strand completion. An aliquot of each PCR 
product was examined by agarose gel electrophoresis. Each run included a negative control, 
consisting of a reaction mixture with water instead of DNA template.  
3.7.1 Detection of amplified products 
Following PCR amplification, all reactions were fractionated on a 2.0% agarose gel 
containing 0.17L 1 x TAE buffer. Gel electrophoresis at 85 volts for 1.5 hours was performed 
using a using a Subcell tank (BioRad Laboratories, Hercules, Calfornia, USA) and immersing 
in 1 x TAE buffer. The gel was visualized by 10µg/ml ethidium bromide (Sigma Chemical 
Co., St. Louis, Missori, USA) under ultra-violet light illumination (FotoPrep R, Fotodyne Inc, 
New Berlin, Wisconsin, USA) to view the anticipated molecular size. 
3.8 Statistics analysis 
The statistical package for sciences (SAS Institute Inc. Cary, NC, USA) version 8.2 was used 
to analyze the data.  Univariate association between Cryptosporidium infection and possible 
risk factors were assess using Pearson‘s χ2 test and Fisher‘s exact test. The odds ratio (OR) 
and the corresponding 95% confidence interval (Cl) were calculated to measure the strength 
of association. P-values < 0.05 were required for significance.  
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CHAPTER FOUR 
4.0   RESULTS 
Section A:  Symptomatic prevalence studies 
4.1   Microscopic detection of cryptosporidium oocysts 
A total of hundred and eighty (180) samples consisting of 35 HIV positive-diarrhoea patients, 
125 HIV-negative-diarrhoea patients and 20 apparently healthy control subjects were 
examined over a period of one and half (1
1
/2) years. Cryptosporidium oocysts was detected in 
47 (26.1%) of the 180 stool samples by staining with modified Ziehl-Neelsen stain. Oocysts 
were found in 13 (37.1%) HIV-positive diarrhoea and 34 (27.2%) HIV-negative diarrhoea 
patient stools. However, because there are marked differences and most oocysts measure 4-6 
micrometer, appear nearly spherical, and have obscure internal structures, we were not able to 
detect any significant morphologic differences between species, although they were 
statistically significant (P<0.05). Consequently, we rely on a combination of data results from 
the morphometrics, molecular techniques, and host specificity of cryptosporidium. 
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A B 
               HIV-positive diarrhoea patient                     HIV- negative diarrhoea patient                 
Figure 4.0: Cryptosporidium oocysts stained pinkish red when examined at 200–400× 
magnification on a Zeiss Axioscop epi-fluorescent microscope  and were observed as thick 
walled, round structure approximately 4-6µm in diameter. 
 
4.2 Clinical and epidemiological data by ELISA assay 
The variables linking epidemiological risk factors and prevalence of the parasite between 
HIV- positive diarrhoea and HIV-negative diarrhoea patients as analyzed by the univariate 
analysis are shown in Table 4.0 below. 
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Table 4.0: Risk factors of Cryptosporidium infection associated with prevalence in HIV-positive and HIV-negative diarrhoea patients. 
 HIV-Positive HIV-negative 
 
Variable N Diarrhoea (%)    OR (95% Cl) 
 
   χ2 P- value N Diarrhoea (%)   OR (95% Cl)    χ2 P- value 
Age(years)   0.75 (0.34-1.62) 7.233 0.204   0.92 (0.68-1.23) 5.839 0.322 
18 -30 2 1 (50.0)    8 7 (87.5)    
31- 43 13 13 (100)    34 27 (79.4)    
44 -56 5 4 (80.0)    11 6 (54.5)    
57- 69 10 8 (80.0)    31 23 (74.2)    
70- 82 3 3 (100)    25 21 (84.0)    
83- 95 2 1 (50.0)    16 6 (37.5)    
Gender   1.39 (0.30-6.23) 0.181 0.670   1.50  (0.63-3.50) 0.852 0.356 
Male  11 7 (63.6)    34 25 (73.5)    
Female 24 19(79.2)    91 71 (78.0)    
Water source    1.79 (0.32-9.90) 0.399 0.528    1.24 (0.42-3.69) 1.179 0.271 
Tap 17 9 (52.9)    65 55 (84.6)    
River 8 7 (87.5)    15 14(93.3)    
Mixed 10 6 (60.0)    47 41 (87.2)    
Contact with 
 farm animals 
  0.16 (0.03-0.97) 4.525 0.033   0.51 (0.02-0.14)     45.935 <.0.001 
Yes 28 23 (82.1)    92 78 (84.8)    
No 7   3 (42.9)    34 8 (23.5)    
Sanitary facility   10.93 (1.8763.97) 8.426 0.004   4.80 (0.39-58.01) 1.667 0.197 
Flush 24 7 (29.2)    90 35 (38.9)    
Pit 11 9 (81.8)    38 27 (71.1)    
Socioeconomic 
status 
  0.58  (0.10-0.32) 1.125 0.890   1.69 (0.66-4.28)     19.524 0.034 
Low income 21 18 (85.7)    60 50 (83.3)    
Average  8 4 (50.0)    19 11 (57.9)    
      High 6 2 (33.3)    45 6 (13.3) 
 
   
N=Total number of patients, P-value for significance; OR, odd ratio; Cl, confidence interval 
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4.3 Cryptosporidiosis infection in HIV-positive and HIV-negative diarrhoea patients 
Cryptosporidium antigen was detected in 26 (74.3%) of 35 HIV-positive and 96 (76.8%) of 
125 HIV-negative diarrhoea patients respectively. None of the 20 apparently healthy controls 
subjects was found to be infected with Cryptosporidium. Overall antigen prevalence of 67.8% 
was detected in 122 of the 180 subjects enrolled. 
4.4 Demographic data and socio-economic risk factors  
The ages between 31-43 (mean age 36.5 yr) and 70-82 (mean age 75.8 yr) had a higher 
prevalence (100%) of the antigen than 18-30 (mean age 23.2 yr) and 83-95 (mean age 88.8 
yr) (50.0%) in HIV-positive diarrhoea patients (P > 0.05; OR = 0.75, 95% Cl: 0.34-1.62). In 
HIV-negative diarrhoea patients, the prevalence was highest in the 18-30 (mean age 23.2 yr) 
(87.5%) and least (35.7%) in those aged 83-95 (mean age 88.8 yr) (P > 0.05; OR = 0.92, 95% 
Cl: 0.68-1.23).  
 
 
 
Keys: % + (HIV++dia) = HIV-positive diarrhoea patient 
 % + (HIV-+ dia) = HIV-negative diarrhoea patient  
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Figure 4.1: Prevalence of cryptosporidiosis in HIV-positive diarrhoea and HIV-negative 
diarrhoea patients.  
The prevalence of Cryptosporidium antigen was higher in females than in males with a ratio 
of approximately 1:4. Of 115 female (mean age 46.7yr) who participated in the study, the 
antigen was detected in 90 (78.2%) against 32 (71.1%) of 45 males (mean age 42.6yr). There 
was no statistically significant association between HIV-positive male and female diarrhoea 
patients (P > 0.05; OR = 1.39, 95%Cl: 0.30-6.23) and HIV-negative male and female 
diarrhoea patients (OR=1.50, 95% CI: 0.63-3.650). 
 
 Cryptosporidium antigen was higher in those who used river and mixed water sources than 
in those who used tap water. A significantly higher (P < 0.05) prevalence of antigen was 
observed in HIV-negative diarrhoea than HIV-positive patients considering contact with farm 
animals as a risk factor. Table 4.0. Prevalence of antigen was significantly higher (P < 0.05) 
among HIV-negative diarrhoea patients than in HIV-positive diarrhoea patients as per socio-
economic status. Prevalence peak was detected in low income (85.7%) of HIV-positive 
diarrhoea patients than high income (32%) of same category of patients. 
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Keys: % + (HIV++dia) = HIV-positive diarrhoea patient 
% + (HIV-+ dia) = HIV-negative diarrhoea patient  
Figure 4.2: Correlation of independent factors associated with disease prevalence.  
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4.5 DNA amplification by direct PCR 
Cryptosporidium positive samples yielded products of the expected size about 599bp in the PCR 
analysis of the SSUrRNA gene. This was less sensitive than ELISA. Of the 180 subjects samples 
amplified, Cryptosporidium species was detected in 112 (62.2%). Amplification yielded band 
fragments which indicated the presence of Cryptosporidium species (Fig 4.3). No amplification 
of DNA was detected in the negative-controls. 
 
Figure 4.3: Amplification products were confirmed using PCR from DNA. The 599 bp 
amplicons were visualized on 2·0 % agarose electrophoresis gels. Lane 12 was loaded with a 
100 bp standard; lane 11; negative control containing al1 reaction products and no DNA; lane 1, 
2, 3, 4, 5, 6, 7, 8, 9, and 10 are HIV-negative diarrhoea results showing C. species.   
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Figure 4.4: Amplification products from the PCR reaction of the 18S (rRNA) region of 
Cryptosporidium isolates observed on 2.0% agarose electrophoresis gels stained with ethidium 
bromide. 12, 100bp DNA ladder; lane 11, negative control containing al1 reaction products and 
no DNA; lane 1,  2, 3, 4, 5, 6, 7, 8, 9, and 10 are HIV- positive diarrhoea results showing C. 
species.   
Section B: Evaluation of three different techniques used for Cryptosporidium species 
detection 
4.6 Comparative evaluation of techniques for cryptosporidium detection 
 
Cryptosporidium was detected in 27 HIV-positive and 97 HIV-negative diarrhoea patients by 
any one of the techniques. Antigen detection by ELISA showed the highest positivity 96 (76.8%) 
in HIV- negative diarrhoea and 26 (74.3%) in HIV- positive diarrhoea patients, followed by 
PCR.  Eighty-nine (71.2%) HIV-negative and 23 (65.7%) HIV-positive patients with diarrhoea 
were found positive for Cryptosporidium. PCR inhibitors were not detected in any of these 
samples. Crossover contaminations were ruled out, because all water and reaction mix controls 
were negative. The sensitivity of the PCR assay and the antigen ELISA was identical (96.5%, 
95% CI: 89% to 99.5%). However, the PCR assay did not disclose more cases of 
cryptosporidiosis in addition to those already detected by the ELISA assay; only 13 (37.1%) 
HIV-positive diarrhoea and 34 (27.2%) HIV-negative diarrhoea patients were found positive for 
Cryptosporidium by modified ZN. 
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Table 4.1: Cryptosporidium positivity by one or more techniques 
 
mZN Antigen 
detection by 
ELISA 
PCR HIV-positive diarrhoea  
(n = 35) 
HIV-negative diarrhoea 
(n = 125) 
Healthy controls  
(n = 20) 
+ + + 12 (34.3%) 31 (24.8%) Nil 
+ - + 1 (2.9%) Nil Nil 
- + + 2 (5.7%) Nil Nil 
- +  - 4 (11.4%) 8 (6.4%) Nil 
- + + 8 (22.9%) 57 (45.6%) Nil 
+ - + Nil 1 (0.8%) Nil 
- - - 8 (22.9%) 28 (22.4%) Nil 
mZN = Modified Ziehl-Neelsen staining, ELISA = Enzyme linked-immunosorbent assay, PCR = 
Polymerase chain reaction, + = High Cryptosporidium detection, - = Negative detection. 
 
Number of samples positive for Cryptosporidium by one or more techniques is shown in Table 
4.1. Twelve (34.3%) and 31 (24.8%) patients were found positive by all the three techniques in 
HIV-positive and HIV-negative diarrhoea patients, respectively; 4(11.4%) HIV-positive and 8 
(6.4%) HIV-negative diarrhoea patients were found positive by only antigen detection. None of 
the patients was found positive by only staining or PCR techniques in both HIV-positive and 
HIV-negative diarrhoea groups. One patient each in the HIV-positive and HIV-negative 
diarrhoea group was found negative by ZN staining and positive by either ELISA or PCR. None 
of the 20 healthy controls was found positive for Cryptosporidium by any of the techniques. 
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4.7 Overall correlation 
Performance of overall correlation values based on sensitivity, specificity, positive predictive 
value, and negative predictive value of the techniques were assessed to define the best possible 
criteria of true positive for detecting Cryptosporidium species. Table 4.2.  
Table 4.2: Sensitivity, specificity, positive predictive value and negative predictive value of 
the techniques. 
 
Techniques HIV status Patients‘ 
positive (%) 
Sensitivity          
     (%)                
Specificity 
(%)                  
Positive 
predictive value       
       (%) 
Negative 
predictive value        
       (%) 
 
ZN 
Positive 13 (37.1%) 46.2 88.9 92.3 36.4 
 Negative 34 (27.2%) 32.3 96.6 96.9 30.1 
Antigen 
detection 
ELISA 
Positive 26 (74.3%) 92.3 36.4 46.2 88.9 
 Negative 96 (76.8) 96.9 30.1 32.3 96.9 
PCR Positive 23(65.7%) 75.0 42.1 52.2 66.7 
 
Negative 89 (71.2%) 96.9 32.6 79.5 77.8 
 
On comparison based on criteria of true positive, the sensitivity of ZN staining technique was 
46.2% in HIV-positive diarrhoea and 32.3% in HIV-negative diarrhoea patients, respectively. No 
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significant difference was observed in sensitivity of antigen detection ELISA and PCR (96.9%) 
in HIV-negative diarrhoea patients, respectively. Specificity of the staining technique was 88.9% 
in HIV-positive diarrhoea and 96.6% in HIV-negative diarrhoea patients. No significant 
difference (P > 0.05) was found in specificity of antigen detection ELISA and PCR in HIV-
positive and HIV-negative diarrhoea patients, respectively. The positive predictive value of ZN 
staining in HIV-positive and HIV-negative diarrhoea patients was 92.3 and 96.9% respectively, 
which was statistically higher than the ELISA and PCR results. No significant difference was 
observed in the negative predictive value of ZN technique for the detection of Cryptosporidium 
between HIV-positive and HIV- negative diarrhoea patients.  
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CHAPTER FIVE 
5.0 Discussion 
The present study was stimulated by an interest in health concerns of the population living in the 
Alice settlement of the Eastern Cape Province. Cryptosporidium diseases attributable to 
environmental contamination occur more commonly in other regions of Limpopo Province 
(Moodley et al., 1991; Obi and Bessong, 2002). However, no information exists regarding 
infection in the Eastern Cape Province. Cryptosporidium infection in residents of the Alice 
districts is of particular interest because these districts are populated by families of lower 
socioeconomic status, and typically have a substandard water supply and limited sanitation 
facilities (Xuza, 2007). 
 
Cryptosporidium is a well established cause of diarrhoea among HIV infected patients 
worldwide with prevalence of infection ranging from 3% in developed countries to 50% in 
developing countries (Framm and Soave, 1997). The prevalence of cryptosporidiosis in Alice 
patients as revealed in this study was 67.8% (122 of 180).  This is higher than the 25 – 35% 
reported in other studies conducted in Varanasi, India (Attili et al., 2006). However, a study 
along the Mexican/US border reported a prevalence of 86.0% cryptosporidiosis in both 
immunocompromised and immunocompetent patients (Redlinger et al., 2002). Our study 
supports these findings because prevalence rate was 16% lower than Mexico study 
cryptosporidiosis in both immunocompromised and immunocompetent patients. 
 
Symptomatic cryptosporidiosis has been found more severe in HIV infected persons (Carcamo et 
al., 2005). Our present study showed a relatively high prevalence rate of 74.3% among HIV 
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infected diarrhoea patients, higher than the rates reported from other African studies. A study 
conducted in Tanzania, reported a prevalence of 17.3% amongst HIV-infected patients (Smith 
and Corcoran, 2004), and in Ethiopia, a prevalence of 29% was documented in HIV patients with 
chronic diarrhoea (Tadesse and Kassu, 2005). These differences may be linked to the varied 
study populations used in the various studies.  
 
Cryptosporidium antigen levels was higher in females (78.3%) than in males (71.1%), however 
this was not statistical significance (P >0.05). This result differs from the findings of previous 
reports in Brazil (Okafor et al., 1994; Mahgoub et al., 2004; Gatei et al., 2006), in which a 
higher prevalence rate was reported in males than in females. However, our observations are in 
conformity with a study in Nigeria where an increased prevalence was found in females 
(Salsirisampant et al., 2002). About 156 of Thai HIV-positive patients showed a prevalence of 
12.8% cryptosporidiosis (10.0% in male and 19.1% in females) (Doyle, 1995). In Brazil, 9.33% 
of samples were positive for Cryptosporidium, with higher frequency of cases in male patients 
from 20 to 50 years old (Mahgoub et al., 2004). Moreover, in rural communities of developing 
countries, females may be more susceptible to diarrhoea disease as they are the primary 
caregivers for children, and are therefore more frequently in contact with their stools samples 
diapers and lack of clean water. This could potentially lead to infection as a result of poor 
hygiene. Females are also fed less, given less nutritious food, provided with less health care and 
given more work (Garvey and McKeown, 2006).  
Our study on Cryptosporidium patients is a pilot in a rural country of the Eastern Cape Province. 
The prevalence rate of 67.8% (122 of 160) reported among HIV-positive and HIV-negative 
diarrhoea patients is similar to rates reported in the Ireland (Inuugu et al., 2000).This indicates 
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that cryptosporidiosis is an important opportunistic parasitic disease causing diarrhoea among 
South Africans in our study population. 
 
The highest prevalence of antigenamia (100%)  in our study occurred in young adults (31-43yr), 
100% in old people (66-80) among HIV-positive diarrhoea patients, while in HIV-negative  
diarrhoea patients, prevalence was higher in 18-30 yr (87.5%) of age to 84.0% in adults aged 70-
82 yr, but less (54.5%) in adults aged 34-56 to patient aged 83-95yr. This pattern is consistent 
with similar observations by other investigators (Naumove et al., 2003; Florez et al., 2003; 
Steinberg et al., 2004). These findings, therefore suggest that Cryptosporidium detection rate can 
vary remarkably depending on the age of the patients. Elderly people appear to be at a greater 
risk of severe disease due to Cryptosporidium infection, as they are inactive and always with 
children who might be infected with cryptosporidiosis, by trying to change their diapers and as a 
result, they are at a high risk of secondary person-to-person transmission (Florez et al., 2003). 
Similar studies in Kajang, India indicated a risk of 15%. Thus diarrhoea illnesses in elderly 
people are on the rise.  
 
Access to potable water and good toilet patterns remains a factor that plays a major role of 
acquiring cryptosporidiosis in this region. The prevalence was higher in those who used river 
water in both HIV-positive and HIV-negative diarrhoea patients (87.5%) and (93.3%) 
respectively, than in those who used tap water, but this was not statistically significant (P> 0.05; 
OR = 1.79). Similarly, those who used a pit toilet had a prevalence of (81.8%) and (71.1%) in 
both HIV-positive and HIV-negative diarrhoea patients respectively (OR =10.93), than those 
who used flush toilet in both HIV-positive (29.2%) and HIV-negative diarrhoea patients 
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(38.9%), but this was not statistically significant (P > 0.05) (OR = 4.80).The odd ratios indicated, 
however, that those who use river water and pit toilets are more likely to be infected by the 
parasite. Significant difference (P<0.034) was observed more in the low socioeconomic group 
among HIV-negative diarrhoea patients than in those of HIV-positive diarrhoea patients (P < 
0.05). 
 
The importance of zoonotic transmission as a wide spread cause of diarrhoea is well recognized. 
We observed a prevalence of 82.1% and 84.8% in both HIV-positive and HIV-negative 
diarrhoea human contact with domestic animals. This result was in agreement with prior studies 
from North-Eastern Spain pet ownership, especially dogs and farm animals. C. meleagridis and 
C. felis were detected in both immunocompetent and immunocompromised patients (Causape et 
al., 2002; Hunter and Thompson, 2005; Chalmers et al., 2006). However, animal-human mixing 
patterns and access to potable drinking water are all factors that play a major role in the risk of 
acquiring cryptosporidiosis and are different from region to region.  
The second part of the present study was an attempt to evaluate three different diagnostic 
techniques on stool specimens of HIV-positive and HIV-negative diarrhoea individuals living in 
the study area.  Laboratory diagnosis of cryptosporidiosis relies on the recognition by 
conventional light microscopy of morphological features specific to the parasite oocyst. 
However, this technique is laborious, and can be insensitive and prone to error when performed 
by inexperienced staff (Bialek et al., 2002). Studies comprising three different techniques, i.e. 
modified ZN staining, antigen detection by ELISA and PCR for the detection of 
cryptosporidiosis is necessary so as to find out the best possible diagnostic marker for the 
diagnosis of cryptosporidiosis. 
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Our findings showed a high incidence of cryptosporidiosis in the 160 adults whose stools we 
examined. The highest positivity was shown by antigen detection (76.8% in HIV- negative and 
74.3% in HIV- positive diarrhoea patients), followed by PCR (71.2% in HIV-negative and 
65.7% in HIV-positive diarrhoea) and ZN staining (37.1% in HIV-positive and 27.2% in HIV-
negative diarrhoea patients).   
Earlier reports from Chennai using ZN staining detected 12% Cryptosporidium from patients 
with HIV-positive and HIV-negative diarrhoea stool samples (Kumar et al., 2002), 3.4% from 
India (Nagamani et al., 2007), 2.7% from Tunisia (Rym et al., 2007) and 29.6% from Peru 
(Vitaliano et al., 2008). Also, other reports documented from India revealed 0.06% 
Cryptosporidium in adults from Chandigarh (Sethi et al., 1999), and 1.5% from Pondicherry 
(Parija et al., 2003). Reports from France indicated 37.3% Cryptosporidium in stool samples of 
HIV-positive diarrheoa patients (Chintu et al., 1995), 21.5% from Zambia (Brandonisio et al., 
1999), 50% from South Italy (Oguntibeju, 2006) and 2.2% from Australia  (Stark et al., 2007). In 
our study, Cryptosporidium was detected in 34 (27.2%) HIV-negative diarrhoea patients by ZN 
staining.  
In the present study, ZN staining showed a sensitivity of 46.2% and in HIV-positive and 32.3% 
in HIV-negative diarrhoea patients, respectively. Studies have reported a sensitivity of 83.7% for 
microscopy; however, the HIV status of the patients was not mentioned (Morgan et al., 1998). 
Cryptosporidium oocyst is very small in size and can easily be mistaken in stool debris for 
artefacts. Also, it is easy to confuse with other oocysts, such as those of Cyclospora species and 
cells, especially yeast cells, which resemble Cryptosporidium oocysts in size and morphology 
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(Connelly et al., 2008). Using this method we could not differentiate between Cryptosporidium 
species oocysts which take a red to pink colour, and other faecal components. 
In the present study, the antigen detection method (ELISA) gave the highest number of positive 
samples, 96 (76.8%) in HIV-negative and 26 (74.3%) in HIV-positive diarrhoea patients. This is 
in accordance with earlier reports from the Mexican/US border indicating an ELISA positivity of 
86.0% cryptosporidiosis in both immunocompromised and immunocompetent patients 
(Redlinger et al., 2002). This is the first time the antigen detection (ELISA) test is being used in 
the Nkonkobe Municipality of the Eastern Cape Province. Our prevalence is higher than that 
previously reported in the Limpopo province 13% (Samie et al., 2006). This procedure revealed 
a clear Cryptosporidium antigen; other parasites could not be detected by this method. In the 
healthy human controls, no antigen was found. Cryptosporidial infection in this case could be 
asymptomatic, according to Casemore (2004). 
In comparison with other methods, this method showed a high sensitivity of 92.3% only in HIV-
positive diarrhea stools than other methods. So we were able to detect Cryptosporidium species 
even when present in low numbers in the samples and large numbers of samples could be 
screened. Our findings support and agree with other studies which reported that using fluorescent 
monoclonal reagents increased the sensitivity and specificity of the detection of Cryptosporidium 
oocysts. It provides an excellent screening method and offers a useful technique for 
epidemiological studies, and hence, control of the parasite (Xiao and Herd, 1993; Alles, 1995). 
No significant difference (P > 0.05) was observed in sensitivity and specificity  of antigen 
detection by ELISA and PCR  in HIV-negative diarrhoea patients, respectively, which is in 
agreement with an earlier study in Bangladesh whereby sensitivity, specificity, positive and 
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negative predictive value had no significant differences (Bialek et al., 2002; Weitzel et al., 
2007). Ubiquitous PCR inhibitors in faecal specimens have been found to cause significant 
problems, therefore, in this study, a commercial kit (Zymo-research faecal kit) was used that 
guarantees reproducibility and simplicity; although in PCR, there is a greater chance of 
contamination especially in a clinical microbiology laboratory handling infectious diseases. 
There is need to take extreme precaution to avoid contamination and therefore, we used negative 
controls with every PCR to check the contamination. 
 
In our study, comparative analysis of three techniques revealed that Cryptosporidium could be 
detected by either ZN, antigen detection (ELISA) or PCR respectively. The number of 
Cryptosporidium positive patients by any one or more techniques was 34.3% and 24.8% in HIV-
positive and HIV-negative diarrhoea patients respectively. The prevalence of Cryptosporidium in 
HIV-positive patients with diarrhoea was significantly different as compared to those in HIV-
negative patients without diarrhoea (p < 0.05). An earlier study from Vellore, India reported that 
Cryptosporidium was significantly higher in HIV-positive patients with diarrhoea (22.6%) as 
compared to 0.5% in patients without diarrhoea by ZN staining (Mukhopadhya et al., 1999; 
Mohandas et al., 2002). Cryptosporidium positivity was 11.4% in HIV-positive and 6.4% in 
HIV-negative diarrhoea patients by only antigen detection (ELISA). None of the patients were 
found positive by only staining or PCR techniques in both HIV-positive and HIV-negative 
diarrhoea groups. One patient each in HIV-positive and HIV-negative diarrhoea group was found 
negative by ZN staining and positive by either ELISA or PCR. None of the 20 healthy controls 
were found positive for Cryptosporidium by any of the techniques. 
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5.1 Conclusion 
From the results of this study, the following conclusions can be drawn:  
1. Cryptosporidium antigen was detection in faeces using ELISA with a prevalence of 96 
(76.8%) in HIV- negative and 26 (74.3%) in HIV- positive diarrhoea patients. The antigen was 
higher in females (78.3%) than in males (71.1%), but were not statistical significance (P >0.05).  
 
2. The prevalence of cryptosporidiosis in the Nkonkobe Municipality was 67.8% (122 of 180). 
The highest prevalence (100%) was found in young adults aged 31-43yr among HIV-positive 
diarrhoea patients, while in HIV-negative diarrhoea patients, prevalence was highest in the 18-30 
yrs (87.5%) age group.  
  
3. To the best of our knowledge there was no relationship between antigenenamia and oocysts 
presence in stool. However, comparing the two techniques (mZN and ELISA), the modified 
Ziehl-Neelsen (mZN) staining was less sensitive for Cryptosporidium detection (37.1%) in  HIV-
positive and HIV-negative (27.2%)  patients with diarrhoea and this suggests that cases of 
cryptosporidiosis may be missed in patients who have diarrhoea if only mZN staining technique 
is employed. ELISA was more sensitive in detecting Cryptosporidium antigen in both HIV-
positive (74.3%) and HIV-negative (76.8%) diarrhoea patients.  
 
4. Preliminary analysis was conducted by PCR to further confirm the presence of 
Cryptosporidium in stool samples of selected subjects. Identification of genotypes circulating in 
the study area could not be done in this particular study due to time and financial constraints. 
However, we are focusing on further studies to elaborate on the genetically distinct genotypes by 
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sequencing the amplified PCR products targeting Cryptosporidium gene at GenBank accession 
no. AF093489. 
 
5.2 Recommendation 
Further studies based on sequencing should focus on the different genotypes and phenotypes of 
Cryptosporidium species to fully delineate the situation. These will be achieved using an ABI 
Prism Dye Terminator Cycle Sequencing kit. Genetic characterization of the epidemiology of 
cryptosporidiosis may identify several novel genotypes/species of Cryptosporidium as well as 
expanding the host range of species in order to better understand the epidemiology and potential 
human health risks of this ubiquitous parasite. To achieve this, the taxonomy of this genus will 
need further evaluation. 
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